EDGAR Filing Documents for 0001493152-17-007886

Form 8-K/A - Current report: [Amend]

SEC Accession No. 0001493152-17-007886

Filing Date

2017-07-18

Accepted

2017-07-17 20:49:18

Documents

Period of Report

2017-07-11

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-ka.htm	8-K/A	29299
2		ex99-3.htm	EX-99.3	126749
3		image_001.jpg	GRAPHIC	4708
4		image_012.jpg	GRAPHIC	53468
5		image_013.jpg	GRAPHIC	11002
6		image_014.jpg	GRAPHIC	10339
7		image_015.jpg	GRAPHIC	84669
8		image_016.jpg	GRAPHIC	49281
9		image_017.jpg	GRAPHIC	15816
10		image_018.jpg	GRAPHIC	69093
11		ex99-3_02.jpg	GRAPHIC	23282
12		image_019.jpg	GRAPHIC	109532
13		image_020.jpg	GRAPHIC	59437
14		image_028.jpg	GRAPHIC	6755
15		image_029.jpg	GRAPHIC	10528
16		image_030.jpg	GRAPHIC	10745
	Complete submission text file	0001493152-17-007886.txt		873208

Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452

Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947

RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)